Prem Watsa - Fairfax Financial Holdings 13F Activity & Position Changes (Q1 2025)

According to the SEC 13F filed on May 15, 2025, the Fairfax Financial Holdings portfolio showed several notable changes in holdings as of quarter-end Mar 31, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2025, the filing reported:

New Buys - Lifeway Foods, Inc.

Increases - Cleveland-Cliffs Inc., The Kraft Heinz Company, Molson Coors Beverage Company

Reductions - Colliers International Group In, KKR & Co. Inc.

Complete Exits - Revance Therapeutics, Inc., TFI International Inc., Xeris Biopharma Holdings, Inc.

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q1 2025	CIGI Colliers International Group In	Colliers International Group In	Sell	-3,000	-12.0%	$2.59M	22,000
Q1 2025	CLF Cleveland-Cliffs Inc.	Cleveland-Cliffs Inc.	Buy	+9,000,000	+152.6%	$122.47M	14,899,273
Q1 2025	KHC The Kraft Heinz Company	The Kraft Heinz Company	Buy	+45,000	+1.4%	$102.18M	3,359,000
Q1 2025	KKR KKR & Co. Inc.	KKR & Co. Inc.	Sell	-3,500	-14.9%	$2.31M	20,000
Q1 2025	LWAY Lifeway Foods, Inc.	Lifeway Foods, Inc.	Buy - Position Entry	+17,367	-	$424.62K	17,367
Q1 2025	RVNC Revance Therapeutics, Inc.	Revance Therapeutics, Inc.	Sell - Position Exit	-21,158	-100.0%	$0.00	-
Q1 2025	TAP Molson Coors Beverage Company	Molson Coors Beverage Company	Buy	+20,000	+1.7%	$73.46M	1,206,500
Q1 2025	TFII TFI International Inc.	TFI International Inc.	Sell - Position Exit	-13,300	-100.0%	$0.00	-
Q1 2025	XERS Xeris Biopharma Holdings, Inc.	Xeris Biopharma Holdings, Inc.	Sell - Position Exit	-139,687	-100.0%	$0.00	-